Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis
Han Chen, Jiao Deng, Tiewei Hou, Yongqi Shan
Topics & Concepts
CDKN2API3K/AKT/mTOR pathwayProtein kinase BCancer researchColorectal cancerMedicineCancerPharmacologySignal transductionBiologyInternal medicineCell biologyBerberine and alkaloids researchNatural product bioactivities and synthesisGenomics, phytochemicals, and oxidative stress